The company was founded in February 2006. The company's strategy focuses on the field of respiratory testing, and also covers various testing fields such as digestive tract, allergens, eugenics, and hepatitis. It features “rapid testing”, “emergency outpatient testing”, and “multi-pathogen differential diagnosis”. It has become one of the leading companies in the field of rapid respiratory POCT detection, and is committed to building a leading brand for rapid respiratory pathogen detection in China, and has become the backbone of medical diagnosis innovation. The company is a high-tech biomedical enterprise focusing on R&D, production and sales of rapid diagnostic products for in vitro diagnosis. The company's main products are respiratory pathogen detection products and digestive tract pathogen detection products.